Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Can B Corp CANB

Can B Corp. is a health and wellness company. It is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. It develops its own line of proprietary products, as well seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. Its products are sold to consumers online, via retailers, marketing partners, and events through doctors and health and wellness organizations.


OTCQB:CANB - Post by User

<< Previous
Bullboard Posts
Next >>
Post by AveragePennyon May 18, 2022 12:08pm
52 Views
Post# 34692545

Can B Corp. Reports First Quarter Revenue Growth of 606%

Can B Corp. Reports First Quarter Revenue Growth of 606%

Key Financial Highlights for Q1 2022

  • Revenue increased 606% to $1.9 million
  • Gross profit increased 291% to $0.7 million
  • Adjusted EBITDA loss decreased 30% to $0.9 million
  • Total assets increased to $17.0 million
  • Total stockholders’ equity increased to $6.2 million

Key Business Highlights for Q1 2022

  • Solidified and integrated vertical processing capabilities from recent acquisitions
  • Advanced build-out of first CBD lounge in Miami, Florida
  • Continuing path for potential NASDAQ up-listing
<< Previous
Bullboard Posts
Next >>